Repository logo
Communities & Collections
Research Outputs
Fundings & Projects
People
Statistics
User Manual
Have you forgotten your password?
  1. Home
  2. Faculty of Medicine
  3. Faculty of Medicine: Journal Articles
  4. Serum Ca 19-9 in pancreatic adenocarcinoma: correlation with hystopathologycal characteristics and a prognostic marker for survival after curative resection
Details

Serum Ca 19-9 in pancreatic adenocarcinoma: correlation with hystopathologycal characteristics and a prognostic marker for survival after curative resection

Journal
Macedonian Journal of Anaesthesia
Date Issued
2021-06
Author(s)
Nikolovska Trpchevska, Emilija
Abstract
Pancreatic cancer is the EU’s third biggest cancer killer, despite being the seventh most common cancer, with the extremely poor outlook for patients. CA19-9 serum levels was eval- uated as a screening tool in asymptomatic individuals and in patients with symptoms related to pancreatic cancer. The aim of the study was to correlate CA19-9 serum level in patients with pancreatic adenocarcinoma with gender, age, grade of differentiation, tumor size and tumor stage. Also, CA19-9 serum level and survival rate was determinate for the period of one year. The study included 62 patients, 40 male and 22 female with pancreatic cancer, diagnosis con- firmed by histopathological examination after surgical treatment. CA19-9 measurements were carried out at certified laboratories. The normal level of CA19-9 was 37U/ml. The patients were divided into 2 groups: the first group with increased CA19-9 level under 100U/ml and the second group with CA19-9 level over 100U/ml. Correlation between histological tumor characteristics including: tumor size, tumor stage and cell differentiation, as well as CA19-9 serum levels, re- vealed insignificant results. However, patients with elevated CA19-9 values higher than 100U/ ml were more frequently measured in patients with larger tumors, advanced III stage of tumor and poorly differentiated tumors. Our study revealed significant correlation between CA19-9 levels and patients’ gender (more in female patients than in male, 90.9% vs 62.5%), age of the patients (older patients) and survival in patients with pancreatic cancer (p=0.022).
File(s)
Loading...
Thumbnail Image
Name

SERUM CA 19-9 IN PANCREATIC ADENOCARCINOMA: CORRELATION WITH HYSTOPATHOLOGYCAL CHARACTERISTICS AND A PROGNOSTIC MARKER FOR SURVIVAL AFTER CURATIVE RESECTION.pdf

Size

763.49 KB

Format

Adobe PDF

Checksum

(MD5):db9f37870366eafedb59f9c628f8ffce

⠀

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Accessibility settings
  • Privacy policy
  • End User Agreement
  • Send Feedback
Repository logo COAR Notify